Influence of EPICardial Adipose Tissue in HEART Diseases: EPICHEART Study (EPICHEART)
Association of the Volume and Proteome of Epicardial Adipose Tissue With Coronary Artery Disease, Left Atrial Remodelling and Atrial Fibrillation in Severe Aortic Stenosis Patients
Sponsor: Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.
Listed as NCT03280433, this observational or N/A phase trial focuses on Atrial Fibrillation and Coronary Arteriosclerosis and remains ongoing. Sponsored by Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E., it has been updated 10 times since 2014, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Dec 2021 — Jul 2024 [monthly]
Unknown Status
-
Jan 2021 — Dec 2021 [monthly]
Unknown Status
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status
▶ Show 5 earlier versions
-
Oct 2019 — Nov 2020 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jun 2018 — Oct 2019 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Oct 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Sep 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.
- Universidade do Porto
For direct contact, visit the study record on ClinicalTrials.gov .